Display options
Cite
Lo Tam Loi AT, Hoonhorst SJ, Franciosi L, et al. Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study. BMJ Open. 2013;3(2)doi: 10.1136/bmjopen-2012-002178.
Lo Tam Loi, A. T., Hoonhorst, S. J., Franciosi, L., Bischoff, R., Hoffmann, R. F., Heijink, I., van Oosterhout, A. J., Boezen, H. M., Timens, W., Postma, D. S., Lammers, J. W., Koenderman, L., & Ten Hacken, N. H. (2013). Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study. BMJ open, 3(2), . https://doi.org/10.1136/bmjopen-2012-002178
Lo Tam Loi, Adèle T, et al. "Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study." BMJ open vol. 3,2 (2013). doi: https://doi.org/10.1136/bmjopen-2012-002178
Lo Tam Loi AT, Hoonhorst SJ, Franciosi L, Bischoff R, Hoffmann RF, Heijink I, van Oosterhout AJ, Boezen HM, Timens W, Postma DS, Lammers JW, Koenderman L, Ten Hacken NH. Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study. BMJ Open. 2013 Feb 01;3(2). doi: 10.1136/bmjopen-2012-002178. Print 2013. PMID: 23377993; PMCID: PMC3586075.
Copy Download .nbib Format: NLM
Share it on

BMJ Open. 2013 Feb 01;3(2). doi: 10.1136/bmjopen-2012-002178. Print 2013.

Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study.

BMJ open

Adèle T Lo Tam Loi, Susan J M Hoonhorst, Lorenza Franciosi, Rainer Bischoff, Roland F Hoffmann, Irene Heijink, Antoon J M van Oosterhout, H Marike Boezen, Wim Timens, Dirkje S Postma, Jan-Willem Lammers, Leo Koenderman, Nick H T Ten Hacken

Affiliations

  1. Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht , The Netherlands.

PMID: 23377993 PMCID: PMC3586075 DOI: 10.1136/bmjopen-2012-002178

Abstract

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with pulmonary and extra-pulmonary manifestations. Although COPD is a complex disease, diagnosis and staging are still based on simple spirometry measurements. Different COPD phenotypes exist based on clinical, physiological, immunological and radiological observations. Cigarette smoking is the most important risk factor for COPD, but only 15-20% of smokers develop the disease, suggesting a genetic predisposition. Unfortunately, little is known about the pathogenesis of COPD, and even less on the very first steps that are associated with an aberrant response to smoke exposure. This study aims to investigate the underlying local and systemic inflammation of different clinical COPD phenotypes, and acute effects of cigarette smoke exposure in individuals susceptible and non-susceptible for the development of COPD. Furthermore, we will investigate mechanisms associated with corticosteroid insensitivity. Our study will provide valuable information regarding the pathogenetic mechanisms underlying the natural course of COPD.

METHODS AND ANALYSIS: This cross-sectional study will include young and old individuals susceptible or non-susceptible to develop COPD. At a young age (18-40 years) 60 'party smokers' will be included who are called susceptible or non-susceptible based on COPD prevalence in smoking family members. In addition, 30 healthy smokers (age 40-75 years) and 110 COPD patients will be included. Measurements will include questionnaires, pulmonary function, low-dose CT scanning of the lung, body composition, 6 min walking distance and biomarkers in peripheral blood, sputum, urine, exhaled breath condensate, epithelial lining fluid, bronchial brushes and biopsies. Non-biased approaches such as proteomics will be performed in blood and epithelial lining fluid.

ETHICS AND DISSEMINATION: This multicentre study was approved by the medical ethical committees of UMC Groningen and Utrecht, the Netherlands. The study findings will be presented at conferences and will be reported in peer-reviewed journals.

TRIAL REGISTRATION: ClinicalTrials.gov, NCT00807469 (study 1) and NCT00850863 (study 2).

References

  1. N Engl J Med. 2011 Sep 29;365(13):1184-92 - PubMed
  2. Clin Diagn Lab Immunol. 2003 Jan;10(1):133-9 - PubMed
  3. J Allergy Clin Immunol. 1991 Nov;88(5):808-14 - PubMed
  4. J Proteomics. 2011 Dec 10;75(1):192-201 - PubMed
  5. J Allergy Clin Immunol. 2007 Nov;120(5):1073-81 - PubMed
  6. Ann Intern Med. 2009 Oct 20;151(8):517-27 - PubMed
  7. Thorax. 2004 Aug;59(8):713-21 - PubMed
  8. J Clin Epidemiol. 2003 Dec;56(12):1163-9 - PubMed
  9. J Laryngol Otol. 2002 Mar;116(3):200-5 - PubMed
  10. J Immunol. 2008 Jun 1;180(11):7622-35 - PubMed
  11. Eur Respir J. 2009 Jul;34(1):95-102 - PubMed
  12. COPD. 2007 Dec;4(4):355-84 - PubMed
  13. Am J Respir Cell Mol Biol. 1992 Jul;7(1):66-72 - PubMed
  14. Injury. 2007 Dec;38(12):1365-72 - PubMed
  15. Am J Respir Crit Care Med. 2010 Dec 15;182(12):1498-505 - PubMed
  16. Respir Res. 2010 Sep 10;11:122 - PubMed
  17. Mol Immunol. 2008 Nov;46(1):91-6 - PubMed
  18. Eur Respir J. 2007 Jan;29(1):64-71 - PubMed
  19. Swiss Med Wkly. 2002 Jan 26;132(3-4):27-37 - PubMed
  20. Am J Respir Cell Mol Biol. 2002 May;26(5):602-9 - PubMed
  21. Eur Respir J. 2008 Jan;31(1):70-7 - PubMed
  22. Am J Respir Crit Care Med. 2003 Jan 1;167(1):24-31 - PubMed
  23. Ann Intern Med. 2005 Feb 15;142(4):233-9 - PubMed
  24. Thorax. 2001 Mar;56 Suppl 1:i1-21 - PubMed
  25. Am J Respir Crit Care Med. 2009 Dec 15;180(12):1170-8 - PubMed
  26. Chest. 2002 Dec;122(6):1909-12 - PubMed
  27. Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55 - PubMed
  28. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7 - PubMed
  29. Respir Med. 2008 Jan;102(1):162-71 - PubMed
  30. Respir Med. 1991 Sep;85 Suppl B:25-31; discussion 33-7 - PubMed
  31. Diabetologia. 2004 Jul;47(7):1324-1330 - PubMed
  32. Eur Respir J. 2005 Aug;26(2):319-38 - PubMed
  33. PLoS One. 2011;6(9):e24395 - PubMed
  34. J Leukoc Biol. 2000 Jul;68(1):58-64 - PubMed
  35. Crit Care Med. 2001 Apr;29(4):896-8 - PubMed
  36. Addict Behav. 2005 Mar;30(3):575-9 - PubMed
  37. J Cell Biol. 1993 Jan;120(2):545-56 - PubMed
  38. N Engl J Med. 2004 Mar 4;350(10):1005-12 - PubMed
  39. J Allergy Clin Immunol. 2005 May;115(5):997-1003 - PubMed
  40. Eur Respir J. 2006 Dec;28(6):1245-57 - PubMed
  41. Am J Respir Crit Care Med. 2011 May 1;183(9):1187-92 - PubMed
  42. Lancet. 2008 Sep 20;372(9643):1107-19 - PubMed
  43. Cytokine. 2011 Nov;56(2):422-9 - PubMed
  44. Eur Respir J. 2008 Apr;31(4):869-73 - PubMed
  45. Pulm Pharmacol Ther. 2005;18(4):297-302 - PubMed
  46. Am J Respir Cell Mol Biol. 2011 Dec;45(6):1147-53 - PubMed
  47. Clin Nutr. 1998 Feb;17(1):15-22 - PubMed

Publication Types